Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
Abstract A subset of breast cancer patients benefits from preoperative bevacizumab and chemotherapy, but validated predictive biomarkers are lacking. Here, we aimed to evaluate tissue-based angiogenesis markers for potential predictive value regarding response to neoadjuvant bevacizumab treatment in...
Saved in:
Main Authors: | Kristi Krüger, Laxmi Silwal-Pandit, Elisabeth Wik, Oddbjørn Straume, Ingunn M. Stefansson, Elin Borgen, Øystein Garred, Bjørn Naume, Olav Engebraaten, Lars A. Akslen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c8a2b3892eea4e2a921d64ce837fe2d4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
by: Olav Engebraaten, et al.
Published: (2021) -
Writing 3D patterns of microvessels
by: Juodkazis S
Published: (2012) -
Fabrication of pillared PLGA microvessel scaffold using femtosecond laser ablation
by: Wang GJ, et al.
Published: (2012) -
Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
by: Dweikat A, et al.
Published: (2021) -
Extracellular vesicle integrins act as a nexus for platelet adhesion in cerebral microvessels
by: Zsolt Bagi, et al.
Published: (2019)